Weight loss market: Smaller rivals muscle in on Eli Lilly and Novo Nordisk
As Eli Lilly and Novo Nordisk continue to dominate the lucrative weight-loss drug market, smaller competitors are gearing up to release their own treatments, aiming to challenge the two industry leaders.
https://anessoft.com/blog/ar/macron-evoque-une-possible-reprise-du-dialogue-avec-vladimir-poutine
As Eli Lilly and Novo Nordisk continue to dominate the lucrative weight-loss drug market, smaller competitors are gearing up to release their own treatments, aiming to challenge the two industry leaders.
What's Your Reaction?
